|
State Contract
Program
The Division of Federal-State Relations
manages various contract programs with states. These contract programs benefits states
with technical training, familiarity with federal requirements and more uniform
enforcement of consumer laws through cooperation and coordination with FDA. The contract
programs allow FDA to enlarge coverage of the Official Establishment Inventory (OEI) and
also to redirect resources to other priorities.
These contract programs include:
Food - Under this program, inspections
are performed in selected food manufacturers/processors to determine compliance with the
Federal Food, Drug and Cosmetic (FD&C) Act, state law, or both;
Feed - Under this
program, inspections of feed establishments are performed to determine compliance
with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and State feed law (if the
contractor's feed law has the provisions of the current AAFCO Uniform State Feed Bill).
Inspections will include assuring compliance with the 21CFR, 589.2000 "Substance
Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant
Feed", commonly known as the "BSE Rule".
Tissue Residue –
Under this program, inspections of producers/owners as identified by USDA/FSIS of a tissue
residue violation are conducted. The primary objectives of the inspection will be to
determine and document the cause of the violative tissue residue. The inspection will
obtain information on the producer’s/owner’s operations, drug usage, animal
husbandry practices, feed delivery systems, responsibility for the violation, and
disposition of any remaining animals. Inspections will include assuring compliance with
the 21CFR 589.2000, "Substance Prohibited from Use in Animal Food or Feed; Animal
Proteins Prohibited in Ruminant Feed", commonly known as the "BSE Rule".
MQSA - The MQSA
contract inspection program is responsible for inspecting mammography facilities that have
been certified by the Food and Drug Administration (FDA) to perform mammography under the
Mammography Quality Standards Act (MQSA) of 1992. The intent of the Act is to ensure that
women receive high quality mammography for early breast cancer detection by requiring the
establishment of a federal certification and inspection program for mammography
facilities. The Act authorizes the FDA to obtain state and local assistance in enforcing
the MQSA requirements including annual inspections of all certified facilities. Trained
inspectors conduct annual inspections of facilities no sooner than 10 months and no later
than 14 months from the last routine annual inspection at a facility. Inspections are
conducted in accordance with FDA Compliance Program 7382.014 "Mammography Facility
Inspections." |
